Several analysts have recently updated their ratings and price targets for Telix Pharmaceuticals (NASDAQ: TLX): 1/27/2026 – Telix Pharmaceuticals had its “buy” rating reaffirmed by analysts at Citigroup Inc.. 1/23/2026 – Telix Pharmaceuticals was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating. 1/21/2026 – Telix Pharmaceuticals had its […]